Obesity

Novo Nordisk A/S Almost a third of adults taking Wegovy® pill (oral semaglutide 25 mg) were early responders…

Here’s something to chew on. Brains require nutrients from a variety of foods like fruits, vegetables, fatty fish,…

The escalating obesity crisis in the UK appears to be reaching a plateau, with researchers suggesting that the…

Coaches and athletes across eight countries say sports clubs could become powerful community health hubs, but only if…

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…

May 12, 2026 At a Glance People with alcohol use disorder and obesity drank less when treated with…

In the Ozempic era, not all pounds lost are met with praise. New research suggests that people may…

Even as GLP-1 medications transform obesity treatment, new research reveals a surprising reality: people may face stigma whether…

Glucagon-like peptide-1 (GLP-1) medications are drugs used to treat type 2 diabetes and support weight loss. They mimic…

Mary Elizabeth Baugh, a research scientist with Virginia Tech’s Fralin Biomedical Research Institute at VTC, has been awarded…

Animals and housing conditions Experiments were performed in accordance with the Animal Protection Law of the European Union…

Childhood obesity remains a major health challenge, and effective interventions often depend on more than nutritional advice or…

Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026